Treatment of women with menopausal syndrome: an alternative to menopausal hormone therapy

Pathological menopause in 26-48% of women is accompanied by vascular, endocrine-metabolic, and neuropsychiatric disorders, which favors the development of somatic disease and substantially reduces quality of life. It is considered as a multifactorial disease, in the development of which the leading role is played by impaired autonomic and hormonal regulation, the decreased adaptive reserves of the hypothalamus and its insufficient adaptability to the changed conditions for the functioning of the hypothalamic-pituitary-ovarian axis. It is always impossible to prescribe menopausal hormone therapy, so a search for alternative therapy for menopausal syndrome remains extremely relevant. In this area, Femoklim (Parafarm, Russia) is one of the promising herbal remedies, an agent that simultaneously affects both triggers of menopausal symptoms, such as estrogen and testosterone deficiency. The authors give the results of their own study assessing cognitive function changes and quality of life indicators in postmenopausal women using the natural non-hormonal agent Femoklim.